MILLENIA HOPE GENERATES SECOND MMH MALAREX SALE

Millenia Hope Inc., a Delaware Biopharma corporation (OTC Bulletin Board: MLHP; Berlin: MLF), today announced that it has sold 10,000 treatments of MMH Malarex(TM)/MMH 18(TM) to a private clinic in Mali. This sale is the initial order from a second contract that could also generate sales of 100,000 treatments over the next 12 months. Previously, on August 10, 2005, Millenia Hope announced its initial African sale of 25,000 treatments from a contract totaling 100,000 treatments spread over the following 12 months. Leonard Stella, CEO, stated, "It is very satisfying to know that we are part of the solution to such an insidious and devastating problem, the malaria plague. Millenia pledges its very best effort to help in curing this killer disease.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-15-2005/0004088310&EDATE=)